4-56655968-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_032495.6(HOPX):c.87G>A(p.Glu29Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0213 in 1,609,038 control chromosomes in the GnomAD database, including 809 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 57 hom., cov: 34)
Exomes 𝑓: 0.021 ( 752 hom. )
Consequence
HOPX
NM_032495.6 synonymous
NM_032495.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.13
Genes affected
HOPX (HGNC:24961): (HOP homeobox) The protein encoded by this gene is a homeodomain protein that lacks certain conserved residues required for DNA binding. It was reported that choriocarcinoma cell lines and tissues failed to express this gene, which suggested the possible involvement of this gene in malignant conversion of placental trophoblasts. Studies in mice suggest that this protein may interact with serum response factor (SRF) and modulate SRF-dependent cardiac-specific gene expression and cardiac development. Multiple alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 4-56655968-C-T is Benign according to our data. Variant chr4-56655968-C-T is described in ClinVar as [Benign]. Clinvar id is 47880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOPX | NM_032495.6 | c.87G>A | p.Glu29Glu | synonymous_variant | 3/4 | ENST00000420433.6 | NP_115884.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOPX | ENST00000420433.6 | c.87G>A | p.Glu29Glu | synonymous_variant | 3/4 | 5 | NM_032495.6 | ENSP00000396275.1 |
Frequencies
GnomAD3 genomes AF: 0.0195 AC: 2970AN: 152118Hom.: 58 Cov.: 34
GnomAD3 genomes
AF:
AC:
2970
AN:
152118
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0300 AC: 7238AN: 241668Hom.: 268 AF XY: 0.0332 AC XY: 4361AN XY: 131284
GnomAD3 exomes
AF:
AC:
7238
AN:
241668
Hom.:
AF XY:
AC XY:
4361
AN XY:
131284
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0214 AC: 31230AN: 1456804Hom.: 752 Cov.: 34 AF XY: 0.0238 AC XY: 17241AN XY: 724458
GnomAD4 exome
AF:
AC:
31230
AN:
1456804
Hom.:
Cov.:
34
AF XY:
AC XY:
17241
AN XY:
724458
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0195 AC: 2973AN: 152234Hom.: 57 Cov.: 34 AF XY: 0.0212 AC XY: 1578AN XY: 74444
GnomAD4 genome
AF:
AC:
2973
AN:
152234
Hom.:
Cov.:
34
AF XY:
AC XY:
1578
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
295
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 20, 2009 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 24, 2017 | Variant summary: The c.87G>A (p.Glu29=; also known as c.33G>A (p.E11=) in NM_139212.3) in HOPX gene is a synonymous change that involves a mildly conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in control dataset of ExAC at a frequency of 0.0365 (3551/ 97210 chrs tested, including 130 homozygotes), predominantly in individuals of South Asian descent (0.12; 1701/ 14110 chrs tested, including 111 homozygotes). These frequencies exceed the estimated maximum allele frequency for a pathogenic allele in this gene (0.000025). The variant of interest has not, to our knowledge, been reported in affected individuals via published reports, but is sited as Likely Benign by a reputable database/clinical laboratory. Taking together, the variant was classified as Benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at